Cochrane · systematic review · CD011177
Zinc supplementation for the treatment of measles in children
Awotiwon, AA, Oduwole, O, Sinha, A, et al. · Cochrane Database of Systematic Reviews · 2017 · Cochrane Library
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
2
current version
GRADE rated
2
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 2 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Current version onlyZinc versus placebo for the treatment of measles in children
Population: children with measles and pneumonia
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Mortality Zinc vs placebo | RR 0.34 [0.01, 8.14] | 1 study · 85 participants | Very low Downgraded: imprecision, indirectness |
Time to fever abatement Zinc vs placebo | HR 1.08 [0.67, 1.74] | 1 study · 78 participants | Very low Downgraded: imprecision, indirectness |
Zinc versus placebo for the treatment of measles in children
Population: children with measles and pneumonia
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Mortality Zinc vs placebo | RR 0.34 [0.01, 8.14] | 1 study · 85 participants | Very low Downgraded: imprecision |
Time to fever abatement Zinc vs placebo | HR 1.08 [0.67, 1.74] | 1 study · 78 participants | Very low Downgraded: imprecision |